Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 06:05 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
A Pilot Study of Dextromethorphan for the Prevention and Treatment of Methotrexate Neurotoxicity
NCT00176553 · University of Medicine and Dentistry of New Jersey · NA · terminated · last registry update 2009-12-11 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “slow accrual” | – | Registry record, University of Medicine and Dentistry of New Jersey |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against SIGMAR1 within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2010-08-26Phase 3 first posted: National Cheng-Kung University Hospital, Dextromethorphan (NCT01189006)
- 2010-08-26Phase 3 first posted: National Cheng-Kung University Hospital, Dextromethorphan + Dextromethorphan (NCT01189097)
- 2010-08-25Phase 3 first posted: National Cheng-Kung University Hospital, Valproate + Dextromethorphan 60 mg per day (NCT01188265)
- 2010-03-24Phase 3 first posted: National Cheng-Kung University Hospital, Dextromethorphan + Silymarin (NCT01091324)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision